MALVERN, Pa., June 26, 2024 (GLOBE NEWSWIRE) -- via IBN – Annovis Bio Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a late-stage clinical drug platform company pioneering transformative therapies ...

I didn’t care about it until my PC wouldn't even POST.

Tevogen Bio files additional AI-related patent to enhance drug discovery and develops T cell therapies for infectious diseases and cancers. Tevogen Bio, a clinical-stage biotech company specializing ...

Tevogen Bio files patent for T cell vaccine targeting entire viral genome, enhancing immune response against mutations and viral infections. Tevogen Bio, a clinical-stage immunotherapy biotech company ...

PHILADELPHIA, Feb. 03, 2022 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (ANPC), a biotechnology company with operations in the United States and China ...

BALTIMORE, Jan. 12, 2026 /PRNewswire/ -- IndyGeneUS Bio today announced the filing of a patent application covering its Clinico-Genomic Insight Engine™ (CGIE™)—a foundational platform under ...

MIAMI BEACH, Fla., July 26, 2024 /PRNewswire/ -- Immorta Bio Inc, a science-based longevity company dedicated to treating "Diseases of Aging and Aging as a Disease™" with personalized cellular ...

Gritstone bio (NASDAQ:GRTS) has filed for Chapter 11 bankruptcy protection in Delaware, according to a court filing. The California-based biotech intends to use the court-administered restructuring ...

On March 20, 2026, Accord, Intas, and Bio-Thera Solutions filed four petitions for inter partes review (“IPR”) challenging Janssen patents related to Simponi ® (golimumab). The petitions are ...

Local life science startup Boundless Bio filed Wednesday to go public — the first San Diego biotech to do so this year. It is the first initial public offering, or IPO, by a local life science firm in ...